Innovative application of confocal Raman spectroscopy and Machine learning in cardiovascular diseases identification.

Journal: Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy
Published Date:

Abstract

Myocardial hypertrophy and heart failure are leading causes of mortality in cardiovascular diseases, yet current diagnostic techniques lack the resolution to monitor molecular changes effectively. In this study, we employed confocal Raman spectroscopy combined with machine learning to evaluate myocardial tissue in a transverse aortic constriction (TAC) mouse model. Mice were divided into three groups: control (CON), myocardial hypertrophy (TAC 2 W), and heart failure (TAC 4 W). The model was validated using echocardiography, histopathology, and transmission electron microscopy. Raman spectroscopy revealed significant changes in chemical composition, including decreased peak intensities at 748, 1309, 1584, 1170, 1359, 1222, 1636, 1335, and 1393 cm, increased intensity at 2847 cm, and a rightward shift of the peak at 2927 cm, which correlated with disease progression. Machine learning analysis demonstrated that the random forest model achieved 85 % accuracy in classifying normal, hypertrophic, and failing myocardial tissues. This study highlights the potential of confocal Raman spectroscopy combined with machine learning for the identification and real-time monitoring of cardiovascular diseases, offering a novel approach to understanding disease mechanisms and improving patient outcomes. Although the model achieved high classification accuracy, the small sample size may limit generalizability and requires further validation in larger cohorts.

Authors

  • Renxing Song
    Research Center for Innovative Technology of Pharmaceutical Analysis, College of Pharmacy, Harbin Medical University, Harbin 150081 Heilongjiang, China.
  • Xunyi Yin
    The Second Affiliated Hospital of Harbin Medical University, Harbin Medical University, Harbin 150081 Heilongjiang, China.
  • Manlin Zhu
    The Fourth Affiliated Hospital of Harbin Medical University, Harbin Medical University, Harbin 150081 Heilongjiang, China.
  • Xinyu Chen
    State Key Laboratory of ASIC and System, School of Microelectronics, Fudan University, Shanghai 200433, China.
  • Jingqi Zhang
    The First Affiliated Hospital of Harbin Medical University, Harbin Medical University, Harbin 150081 Heilongjiang, China.
  • Dongmei Liu
    The Second Affiliated Hospital of Harbin Medical University, Harbin Medical University, Harbin 150081 Heilongjiang, China.
  • Shimei Wang
    The Fourth Affiliated Hospital of Harbin Medical University, Harbin Medical University, Harbin 150081 Heilongjiang, China.
  • Shuang Jiang
    Research Center for Innovative Technology of Pharmaceutical Analysis, College of Pharmacy, Harbin Medical University, Harbin 150081 Heilongjiang, China.
  • Zhehan Liu
    College of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150081 Heilongjiang, China.
  • Lin Wang
    Department of Engineering Mechanics, Tsinghua University, Beijing 100084, China.
  • Kun Feng
    Pingshan District People's Hospital of Shenzhen, Pingshan General Hospital of Southern Medical University, Shenzhen 518118 Guangdong, China. Electronic address: fengkunsz@163.com.
  • Yang Li
    Occupation of Chinese Center for Disease Control and Prevention, Beijing, China.